The company's advancements, supported by patents developed by inventor Robert C. DeMaio, will fundamentally shift the paradigm of data security. The traditional centralized model, which often leads to identity fraud and large-scale data breaches, will be replaced by a decentralized, zero-trust framework where the individual is the sole custodian of their data.
"Clinical research is built on trust—trust from participants, researchers, and regulators. Our Netverse platform will provide the technology to rebuild and strengthen that trust from the ground up," said Phinge CEO Robert DeMaio. "By anchoring patient identity to physical hardware and giving users complete control over their information, we can make clinical trials safer, more efficient, and more inclusive."
Key benefits for the clinical trial industry include:
Elimination of Patient Enrollment Fraud: Phinge® patented hardware-verified identity will ensure that each participant is a unique, real individual, preventing fraudulent enrollment by "professional subjects" and enhancing the integrity of trial results.
- Enhanced Data Integrity and Accuracy: Data from verified Phinge IoT devices, such as its patented magnetically connectable smartphones and smartwatches, is automatically collected with an immutable, hardware-verified signature. This will eliminate manual data entry, reducing transcription errors and ensuring a reliable audit trail.
- Real-time Patient Safety Monitoring: Continuous and objective data collection will allow for instant detection and reporting of adverse events. This will enable researchers to identify safety signals faster and intervene proactively, significantly improving patient safety throughout the study.
- Empowering Participant Engagement: By owning their personal health data, participants become active stakeholders in their own health journey. This transparency and control will lead to higher engagement and retention rates, addressing a critical challenge in long-term studies.
- Secure and Granular Data Access: The Netverse platform will feature a robust, granular consent system. Participants can explicitly grant and revoke access to specific data types and for defined time periods, ensuring their information is never shared without their permission. This is a dramatic shift from traditional all-or-nothing data sharing agreements.
- Monetization of De-identified Data: With explicit consent, participants can choose to monetize their anonymized health data for research purposes. This will provide a direct financial incentive for participation, fostering greater transparency and compensating individuals for their contribution to medical advancements.
Preview Netverse and its patented, magnetically attachable smartphones and devices by visiting Phinge's websites at
https://www.phinge.com
To get on a contact list, please fill out the online form here
https://www.phinge.com/netverseai.html
Ask Google Gemini about Netverse here
https://www.phinge.com/get-netverse.html
View Phinge's Crunchbase profile here
https://www.crunchbase.com/organization/phinge
View Phinge CEO Robert DeMaio's Crunchbase profile here
https://www.crunchbase.com/person/robert-charles-demaio
About Phinge Corporation
Phinge was founded and through Netverse® is being developed to disrupt today's outdated App technologies, including the App-store duopoly, by partnering with and giving its users and businesses ownership and control of their data, enhanced privacy and a better overall mobile experience including their ability to monetize it.
Phinge through its upcoming patented Netverse App-less technology platform with proprietary AI, will be a better, safer, verified and rewarding alternative platform and technology for users and third party businesses and developers to today's App stores, operating systems and ecosystems of Apple, Google and Android.
Netverse will not be an App or Super App that resides on the major technology platforms of today.
Instead, it will be a standalone, all-in-one, app-less platform, accessible only through Phinge's revolutionary, patented, Mobile Hardware which includes Magnetically Attachable/Detachable Phones, Tablets, Mobile Gaming Systems and peripherals like the stylish, wireless earbuds with interchangeable batteries and built-in sensor screens for continuous usage without recharging. Smart Watches that never need to be physically charged as they come with stylish external, interchangeable bezels with built-in rechargeable batteries and come in a variety of colors, patterns and finishes.
Netverse will be a verified, centralized-decentralized platform.
Centralized in the way it provides universal safeguards through verification of all users, businesses, organizations, entities and IP through Phinge's patented Netverse technologies and hardware.
Centralized because Phinge and Netverse will be compliant with all government regulations regarding data and privacy.
Decentralized because all third party platforms will be compliant with all government regulations regarding data and privacy as soon as they are verified and join Netverse.
Decentralized because its users, businesses, organizations and entities will have the power to live, work and thrive in a verified world.
Netverse will benefit all verified users and approved, verified third party businesses, developers and platforms on Netverse in ways not possible with today's technology including total verification of all users, businesses, organizations, platforms.
Photos: (Click photo to enlarge)
Source: Phinge Corporation
Read Full Story - Phinge's Netverse to Redefine Clinical Trial Safety and Data Integrity with Netverse Patented, Hardware-Verified Platform | More news from this source
Press release distribution by PRLog
